The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This section has no associated Explanatory Memorandum

17.  In regulation 27 (amendment of regulation 36 (conditions for manufacturer's licence)) for “, omit paragraphs (4) to (7)” substitute—U.K.

(a)in paragraph (4)—

(i)for “The requirements” substitute “ Where a manufacturer's licence relates to the manufacture or assembly of a medicinal product in, or import of a medicinal product into, Northern Ireland, the requirements ”;

(ii)for “provisions of a manufacturer's” substitute “ provisions of that ”;

(b)in paragraph (6), after “by way of wholesale dealing” insert “ in Northern Ireland ”..

Commencement Information

I1Sch. 2 para. 17 in force at 31.12.2020 immediately before IP completion day, see reg. 1